To view this email as a web page, click here.

 
The Legacy Effect in Type 2 Diabetes
Immediate, intensive treatment for newly diagnosed diabetes patients may be necessary to avoid irreversible long-term risk for diabetic complications and mortality, according to a new large cohort study.
Read more
 
Beta-blockers in Type 2 Diabetes: Time to Reconsider?
Increased risk for CV events and severe hypoglycemia in T2D patients treated with ß-blockers seems reason enough to rethink this Rx.
Read more
ADVERTISEMENT
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.